Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
February 7, 2003
Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease
Carsten Schmidt, Thomas Marth, Bianca M Wittig, et al.
Cancer Research
|
June 18, 2003
Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer
Silke Reinartz, Andreas Hombach, Siegmund Köhler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 22, 2021
IL12 integrated into the CAR exodomain converts CD8<sup>+</sup> T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors
Andreas Hombach, Markus Barden, Lisa Hannappel, et al.
International Journal of Cancer
|
April 20, 2004
Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells
Claudia Heuser, Stefan Guhlke, Alexander Matthies, et al.
Rejuvenation Research
|
July 3, 2008
CD7(-) T cells are late memory cells generated from CD7(+) T cells
Gunter Rappl, David Schrama, Andreas Hombach, et al.
Leukemia & Lymphoma
|
May 24, 2013
Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing
Kerstin Brinkmann, Andreas Hombach, Jens Michael Seeger, et al.
Leukemia & Lymphoma
|
May 29, 2003
Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences
Hinrich Abken, Andreas Hombach, Günter Reinhard, et al.
Blood
|
July 27, 2006
XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack
Hamid Kashkar, Jens-Michael Seeger, Andreas Hombach, et al.
Blood
|
May 18, 2007
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease
Barbara Savoldo, Cliona M Rooney, Antonio Di Stasi, et al.
Plos One
|
March 18, 2021
Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
Christine Ambrose, Lihe Su, Lan Wu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
February 7, 2003
Interleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease
Carsten Schmidt, Thomas Marth, Bianca M Wittig, et al.
Cancer Research
|
June 18, 2003
Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer
Silke Reinartz, Andreas Hombach, Siegmund Köhler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 22, 2021
IL12 integrated into the CAR exodomain converts CD8<sup>+</sup> T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors
Andreas Hombach, Markus Barden, Lisa Hannappel, et al.
International Journal of Cancer
|
April 20, 2004
Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells
Claudia Heuser, Stefan Guhlke, Alexander Matthies, et al.
Rejuvenation Research
|
July 3, 2008
CD7(-) T cells are late memory cells generated from CD7(+) T cells
Gunter Rappl, David Schrama, Andreas Hombach, et al.
Leukemia & Lymphoma
|
May 24, 2013
Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing
Kerstin Brinkmann, Andreas Hombach, Jens Michael Seeger, et al.
Leukemia & Lymphoma
|
May 29, 2003
Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences
Hinrich Abken, Andreas Hombach, Günter Reinhard, et al.
Blood
|
July 27, 2006
XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack
Hamid Kashkar, Jens-Michael Seeger, Andreas Hombach, et al.
Blood
|
May 18, 2007
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease
Barbara Savoldo, Cliona M Rooney, Antonio Di Stasi, et al.
Plos One
|
March 18, 2021
Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
Christine Ambrose, Lihe Su, Lan Wu, et al.
Page
of 3